We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-18.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$33.5B
AUM Growth
-$7.23B
Cap. Flow
+$2.49B
Cap. Flow %
7.42%
Top 10 Hldgs %
22.78%
Holding
819
New
108
Increased
248
Reduced
319
Closed
97

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$349M
2
T icon
AT&T
T
+$127M
3
MMM icon
3M
MMM
+$118M
4
JCI icon
Johnson Controls International
JCI
+$117M
5
LHX icon
L3Harris
LHX
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 20.23%
2 Technology 19.12%
3 Financials 11.7%
4 Consumer Discretionary 10.23%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATY icon
576
Cathay General Bancorp
CATY
$4.26B
$4.71M 0.01%
205,237
+75,237
+58% +$2.41M
KMX icon
577
CarMax
KMX
$8.24B
$4.71M 0.01%
87,400
-103,400
-54% -$8.75M
HBT icon
578
HBT Financial
HBT
$1.32B
$4.65M 0.01%
441,883
+31,883
+8% +$523K
EPAM icon
579
EPAM Systems
EPAM
$4.86B
$4.64M 0.01%
25,000
-35,000
-58% -$7.56M
FG
580
DELISTED
FGL Holdings Ordinary Shares
FG
$4.61M 0.01%
+470,000
New +$4.96M
DRNA
581
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.59M 0.01%
250,000
-150,000
-38% -$2.92M
STOK icon
582
Stoke Therapeutics
STOK
$2.06B
$4.58M 0.01%
+200,000
New +$4.94M
LOGC
583
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$4.52M 0.01%
915,355
-331,199
-27% -$2.58M
ASND icon
584
Ascendis Pharma A/S
ASND
$16.4B
$4.5M 0.01%
40,000
AIT icon
585
Applied Industrial Technologies
AIT
$13.3B
$4.49M 0.01%
+98,099
New +$5.8M
KIM icon
586
Kimco Realty
KIM
$16.4B
$4.43M 0.01%
458,063
-8,700
-2% -$149K
G icon
587
Genpact
G
$6.13B
$4.38M 0.01%
150,000
-550,000
-79% -$21.5M
SLB icon
588
SLB Ltd
SLB
$76.5B
$4.37M 0.01%
323,867
-1,438,600
-82% -$41.6M
DOO
589
Bombardier Recreational Products
DOO
$4.68B
$4.36M 0.01%
+267,282
New +$11M
SEE
590
DELISTED
Sealed Air
SEE
$4.36M 0.01%
176,275
-3,200
-2% -$104K
STRO icon
591
Sutro Biopharma
STRO
$400M
$4.33M 0.01%
42,500
+40,000
+1,600% +$4.2M
ARCH
592
DELISTED
Arch Resources, Inc.
ARCH
$4.33M 0.01%
+150,000
New +$7.68M
ARWR icon
593
Arrowhead Research
ARWR
$12.1B
$4.32M 0.01%
150,000
-25,000
-14% -$1.01M
FOX icon
594
Fox Class B
FOX
$23.2B
$4.28M 0.01%
187,220
+7,030
+4% +$227K
BXC icon
595
BlueLinx
BXC
$671M
$4.27M 0.01%
862,104
-13,600
-2% -$153K
DINO icon
596
HF Sinclair
DINO
$14.7B
$4.23M 0.01%
+172,600
New +$6.45M
DXC icon
597
DXC Technology
DXC
$1.77B
$4.21M 0.01%
322,720
-87,658
-21% -$2.32M
VRT icon
598
Vertiv
VRT
$106B
$4.2M 0.01%
485,000
-2,215,000
-82% -$24.4M
SLG icon
599
SL Green Realty
SLG
$3.86B
$4.19M 0.01%
100,512
-51,998
-34% -$4.05M
HSKA
600
DELISTED
Heska Corp
HSKA
$4.15M 0.01%
+75,000
New +$6.79M

Similar funds

Adage Capital Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Adage Capital Partners held 819 positions worth $33.5B, down 18% from $40.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Adage Capital Partners deployed $2.49B of net new capital in Q1 2020, opening 108 new positions and adding to 248 existing holdings. Its largest new stake was Raytheon Company: 818,400 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $349M trimmed.

  • Adage Capital Partners's largest Q1 2020 buy was Raytheon Company: 818,400 shares worth $107M.
  • Adage Capital Partners added most to Allergan plc in Q1 2020, an estimated $526M increase.
  • Adage Capital Partners's biggest Q1 2020 reduction was RTX Corp, cutting an estimated $349M.
  • Adage Capital Partners fully exited 3M in Q1 2020, selling an estimated $118M.
  • Adage Capital Partners's ten largest holdings make up 23% of its $33.5B portfolio in Q1 2020.
  • Adage Capital Partners opened 108 new positions and closed 97 in Q1 2020.
  • Adage Capital Partners's portfolio value fell 18% quarter-over-quarter to $33.5B.

Based on Adage Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.